TG Therapeutics (TGTX)
NASDAQ:TGTX
Want to see TGTX full AI Analyst Report?
TG Therapeutics (TGTX) Ownership Overview
7.23% Insiders
17.66% Mutual Funds
1.42% Other Institutional Investors
23.24% ETFs
50.44% Public Companies and
Individual Investors
The ownership structure of TG Therapeutics (TGTX) stock is a mix of institutional, retail, and individual investors. Approximately 42.32% of the company’s stock is owned by Institutional Investors, 7.23% is owned by Insiders, and 50.44% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 25, 2025 | xxxxxxxxxxxxx | $162850 | |
Sep 12, 2025 | xxxxxxxxxxxxx | $672268 | |
Jun 16, 2025 | xxxxxxxxxxxxx | $369400 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $607915 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $14006377 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,062,713 | Institution | 9.43% | 521,169,870 | |
| 13,575,368 | Institution | 8.50% | 469,707,733 | |
| 11,593,050 | Institution | 7.26% | 401,119,530 | |
| 9,778,086 | Insider | 6.12% | 338,321,776 | |
| 5,683,736 | Institution | 3.56% | 196,657,266 | |
| 1,530,219 | Institution | 0.96% | 52,945,577 | |
| 1,383,547 | Institution | 0.87% | 47,870,726 | |
| 1,357,377 | Institution | 0.85% | 46,965,244 | |
| 1,303,280 | Institution | 0.82% | 45,093,488 | |
| 1,278,480 | Institution | 0.80% | 44,235,408 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,593,050 | Institution | 7.26% | 401,119,530 | |
| 1,530,219 | Institution | 0.96% | 52,945,577 | |
| 1,383,547 | Institution | 0.87% | 47,870,726 | |
| 1,357,377 | Institution | 0.85% | 46,965,244 | |
| 1,303,280 | Institution | 0.82% | 45,093,488 | |
| 1,278,480 | Institution | 0.80% | 44,235,408 | |
| 1,160,000 | Institution | 0.73% | 40,136,000 | |
| 933,712 | Institution | 0.58% | 32,306,435 | |
| 879,130 | Institution | 0.55% | 30,417,898 | |
| 850,682 | Institution | 0.53% | 29,433,597 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,234,436 | Institution | 5.16% | 284,911,486 | |
| 4,820,157 | Institution | 3.02% | 160,125,616 | |
| 3,482,569 | Institution | 2.18% | 115,690,942 | |
| 3,422,784 | Institution | 2.14% | 118,428,326 | |
| 3,337,257 | Institution | 2.09% | 115,335,602 | |
| 1,951,285 | Institution | 1.22% | 64,821,688 | |
| 1,520,364 | Institution | 0.95% | 50,506,492 | |
| 1,234,314 | Institution | 0.77% | 42,657,892 | |
| 1,187,717 | Institution | 0.74% | 41,095,008 | |
| 1,172,635 | Institution | 0.73% | 40,573,171 |
FAQ
Who Owns TG Therapeutics (TGTX)?
According to the latest TipRanks data, approximately 1.42% of the company's stock is held by institutional investors, 7.23% is held by insiders, and 50.44% is held by retail investors.
What percentage of TG Therapeutics (TGTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.42% of TG Therapeutics (TGTX) stock is held by institutional investors.
What percentage of TG Therapeutics (TGTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 50.44% of TG Therapeutics (TGTX) stock is held by retail investors.
Who owns the most shares of TG Therapeutics (TGTX)?
iShares owns the most shares of TG Therapeutics (TGTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.